These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31584754)

  • 1. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
    McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
    Farzaneh T; Nowroozizadeh B; Han M; Lee W
    Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
    Jiang Y; Xie J; Wang B; Mu Y; Liu P
    Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
    Lu H; Allende D; Liu X; Zhang Y
    Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A limited panel of INSM1 and LEF1 immunostains accurately distinguishes between pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm.
    Guo W; Farzaneh T; Lee W; Nael A; Li X; Chandan VS
    Pathol Res Pract; 2021 Jul; 223():153462. PubMed ID: 34048981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of lymphoid enhancer-binding factor 1 (LEF1) in solid-pseudopapillary neoplasms of the pancreas.
    Singhi AD; Lilo M; Hruban RH; Cressman KL; Fuhrer K; Seethala RR
    Mod Pathol; 2014 Oct; 27(10):1355-63. PubMed ID: 24658583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEF1, TFE3, and AR are putative diagnostic markers of solid pseudopapillary neoplasms.
    Kim EK; Jang M; Park M; Kim H
    Oncotarget; 2017 Nov; 8(55):93404-93413. PubMed ID: 29212159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas.
    Lawlor RT; Daprà V; Girolami I; Pea A; Pilati C; Nottegar A; Piccoli P; Parolini C; Sperandio N; Capelli P; Scarpa A; Luchini C
    Virchows Arch; 2019 Jan; 474(1):105-109. PubMed ID: 30132130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
    Foo WC; Harrison G; Zhang X
    Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations.
    Dinarvand P; Wang WL; Roy-Chowdhuri S
    Cytopathology; 2022 Mar; 33(2):216-221. PubMed ID: 34816516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-Pseudopapillary neoplasm of the pancreas: A clinicopathological review of 20 cases including rare examples.
    Ersen A; Agalar AA; Ozer E; Agalar C; Unek T; Egeli T; Ozbilgin M; Astarcioglu I; Olguner M; Obuz F; Sagol O
    Pathol Res Pract; 2016 Nov; 212(11):1052-1058. PubMed ID: 28327291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-pseudopapillary neoplasm of the pancreas: awareness of unusual clinical presentations and morphology of the clear cell variant can prevent diagnostic errors.
    Zhao P; deBrito P; Ozdemirli M; Sidawy MK
    Diagn Cytopathol; 2013 Oct; 41(10):889-95. PubMed ID: 23584981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
    Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
    Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of cytomorphology in distinguishing solid pseudopapillary neoplasm of pancreas from pancreatic neuroendocrine tumor with emphasis on nuclear folds and nuclear grooves.
    Misra S; Saran RK; Srivastava S; Barman S; Dahale A
    Diagn Cytopathol; 2019 Jun; 47(6):531-540. PubMed ID: 30677247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cercariform cells: another cytologic feature distinguishing solid pseudopapillary neoplasms from pancreatic endocrine neoplasms and acinar cell carcinomas in endoscopic ultrasound-guided fine-needle aspirates.
    Samad A; Shah AA; Stelow EB; Alsharif M; Cameron SE; Pambuccian SE
    Cancer Cytopathol; 2013 Jun; 121(6):298-310. PubMed ID: 23765692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature.
    Hav M; Lem D; Chhut SV; Kong R; Pauwels P; Cuvelier C; Piet P
    Malays J Pathol; 2009 Dec; 31(2):137-41. PubMed ID: 20514858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal and papillary variants of acinar cell carcinomas: a new addition to the challenging differential diagnosis of intraductal neoplasms.
    Basturk O; Zamboni G; Klimstra DS; Capelli P; Andea A; Kamel NS; Adsay NV
    Am J Surg Pathol; 2007 Mar; 31(3):363-70. PubMed ID: 17325477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas.
    Guo Y; Yuan F; Deng H; Wang HF; Jin XL; Xiao JC
    Am J Surg Pathol; 2011 Jun; 35(6):799-806. PubMed ID: 21566515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid-pseudopapillary neoplasm (SPN) of the pancreas: case series and literature review on an enigmatic entity.
    Vassos N; Agaimy A; Klein P; Hohenberger W; Croner RS
    Int J Clin Exp Pathol; 2013; 6(6):1051-9. PubMed ID: 23696922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.